DDIS-24. DECREASE IN GLIOBLASTOMA GROWTH IN VITRO WITH TREATMENT OF NOVEL ANALOGS OF GLUCOSE TRANSPORTER INHIBITORS

Despite available treatments including surgical resection, radiation and chemotherapy, glioblastoma (GBM) is incurable with rapid recurrence and low median survival rate of just fourteen months. Development of more effective treatments is difficult due to the highly heterogeneous nature of GBM. One...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: GC, Sajina, Libby, Catherine, Zhang, Sixue, Benavides, Gloria, Scott, Sarah, Li, Yanjie, Tran, Anh, Otamias, Arphaxad, Darley-Usmar, Victor, Napierala, Marek, Pathak, Vibha, Moukha-Chafiq, Omar, Augelli-Szafran, Corinne, Zhang, Wei, Hjelmeland, Anita
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Drug Discovery
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847344/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.275
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky